Physician profile
Magan Mona
NPI 1295499937
$2,551.53
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $183 · 2023: $1,901 · 2024: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,321 · Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,321.25 |
| Food and Beverage | $884.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,733.36 | 2023-2024 | Axonics |
| Medtronic, INC. | $131.14 | 2021 | |
| Pfizer INC. | $123.97 | 2021-2024 | |
| Progenics Pharmaceuticals, INC. | $121.74 | 2023-2024 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $101.63 | 2022 | |
| Rochester Medical Corporation | $55.89 | 2022 | |
| Abbvie INC. | $45.92 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $37.51 | 2023-2024 | Bard Urinary Drainage Bag |
| Teleflex LLC | $31.79 | 2024 | Urolift |
| Sumitomo Pharma America, INC. | $27.46 | 2023-2024 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $26.34 | 2024 | |
| Heartflow, INC. | $22.43 | 2023 | Ffrct |
| Urogen Pharma, INC. | $18.55 | 2024 | |
| Tolmar, INC. | $17.21 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.96 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.26 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.67 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magan Mona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.